Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.
Jason N. Gorevic, insider at Teladoc Health

Jason N. Gorevic Insider Information

Jason Gorevic is the chief executive officer of Teladoc Health, a virtual healthcare delivery company. 

Gorevic assumed the role of CEO in 2009 and has helped guide the company to become a world leader in virtual delivery of healthcare. He is noted for his passion for providing universal access to care and improving healthcare outcomes. Under his leadership, Teladoc has delivered millions of medical visits across 175 countries. 

Before joining Teladoc Health, Gorevic was the chief sales and marketing officer of Empire BlueCross BlueShield. He was a key member of the leadership team that generated 20 percent growth in annual earnings per share, ultimately leading to 300 percent market cap growth between its 2002 IPO and its 2005 acquisition by WellPoint. 

Gorevic continued to lead Empire BlueCross BlueShield under WellPoint, Inc. (now Anthem, Inc.) as president the chief marketing and product officer. He also became the president of the acquired Lumenos, Inc., driving enterprise-wide adoption of its consumer-directed health plan which became the company’s fastest-growing product. 

The healthcare executive founded Gemfinity, an electronic marketplace and purchasing aggregator, in 2000. Before starting Gemfinity, Gorevic was the senior vice president of business messaging of Mail.com, a provider of Internet messaging services. He helped take the company public after growing it from 40 employees to 1,000. 

Gorevic began his career with Oxford Health Plans in 1993 as the director of service strategy. He helped design and build a first generation telephone medical advice service staffed by Registered Nurses. This method of utilizing health care resources became industry standard. 

He serves on the board of directors of New York Road Runners and holds a B.A. in international relations from the University of Pennsylvania. 

What is Jason N. Gorevic's net worth?

The estimated net worth of Jason N. Gorevic is at least $70.55 million as of June 1st, 2021. Gorevic owns 465,970 shares of Teladoc Health stock worth more than $70,552,518 as of August 3rd. This net worth evaluation does not reflect any other investments that Gorevic may own. Additionally, Gorevic receives a salary of $1,660,000.00 as CEO at Teladoc Health.

How old is Jason N. Gorevic?

Gorevic is currently 49 years old. There are 6 older executives and no younger executives at Teladoc Health.

What is Jason N. Gorevic's salary?

As the CEO of Teladoc Health, Inc., Gorevic earns $1,660,000.00 per year.

How do I contact Jason N. Gorevic?

The corporate mailing address for Gorevic and other Teladoc Health executives is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. Teladoc Health can also be reached via phone at (203) 635-2002 and via email at [email protected]

Has Jason N. Gorevic been buying or selling shares of Teladoc Health?

Jason N. Gorevic has not been actively trading shares of Teladoc Health during the last ninety days. Most recently, Jason N. Gorevic sold 10,000 shares of the business's stock in a transaction on Tuesday, June 1st. The shares were sold at an average price of $153.34, for a transaction totalling $1,533,400.00. Following the completion of the sale, the chief executive officer now directly owns 465,970 shares of the company's stock, valued at $71,451,839.80.

Are insiders buying or selling shares of Teladoc Health?

During the last year, insiders at the health services provider sold shares 59 times. They sold a total of 1,155,059 shares worth mmore than $186,845,867.79. The most recent insider tranaction occured on July, 30th when David William Sides COO bought 3,420 shares worth more than $527,979.60. Insiders at Teladoc Health own 6.5 % of the company.

Information on this page was last updated on 7/30/2021.

Jason N. Gorevic Insider Trading History at Teladoc Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2021Sell10,000$153.34$1,533,400.00465,970View SEC Filing Icon  
5/4/2021Sell10,000$156.48$1,564,800.00484,670View SEC Filing Icon  
4/6/2021Sell25,000$182.19$4,554,750.00507,970View SEC Filing Icon  
3/5/2021Sell20,220$183.18$3,703,899.60548,296View SEC Filing Icon  
1/5/2021Sell30,000$200.15$6,004,500.00557,188View SEC Filing Icon  
12/3/2020Sell5,000$200.52$1,002,600.00607,318View SEC Filing Icon  
10/6/2020Sell30,000$222.26$6,667,800.00697,283View SEC Filing Icon  
8/4/2020Sell30,000$245.96$7,378,800.00697,283View SEC Filing Icon  
7/7/2020Sell30,000$218.71$6,561,300.00697,283View SEC Filing Icon  
6/2/2020Sell25,000$168.42$4,210,500.00694,350View SEC Filing Icon  
5/5/2020Sell40,000$170.26$6,810,400.00711,283View SEC Filing Icon  
5/16/2019Sell20,000$61.17$1,223,400.00663,924View SEC Filing Icon  
4/16/2019Sell30,000$53.04$1,591,200.00673,924View SEC Filing Icon  
3/19/2019Sell30,000$63.16$1,894,800.00653,851View SEC Filing Icon  
2/19/2019Sell30,000$69.68$2,090,400.00631,875View SEC Filing Icon  
1/18/2019Sell30,000$63.04$1,891,200.00633,719View SEC Filing Icon  
12/19/2018Sell30,000$49.55$1,486,500.00536,184View SEC Filing Icon  
11/19/2018Sell35,000$54.80$1,918,000.00541,184View SEC Filing Icon  
10/17/2018Sell25,000$70.29$1,757,250.00511,184View SEC Filing Icon  
9/17/2018Sell25,000$75.05$1,876,250.00536,184View SEC Filing Icon  
8/16/2018Sell25,000$71.66$1,791,500.00561,184View SEC Filing Icon  
7/16/2018Sell25,000$66.11$1,652,750.00586,184View SEC Filing Icon  
6/15/2018Sell25,000$60.21$1,505,250.00611,184View SEC Filing Icon  
5/15/2018Sell25,000$48.93$1,223,250.00636,184View SEC Filing Icon  
4/16/2018Sell25,000$41.36$1,034,000.00661,184View SEC Filing Icon  
3/12/2018Sell40,000$43.27$1,730,800.00View SEC Filing Icon  
12/4/2017Sell100,000$32.99$3,299,000.00718,261View SEC Filing Icon  
11/2/2017Sell20,000$32.10$642,000.00838,261View SEC Filing Icon  
10/2/2017Sell20,000$33.47$669,400.00View SEC Filing Icon  
6/6/2017Sell19,991$32.89$657,503.99831,650View SEC Filing Icon  
6/5/2017Sell13,389$32.89$440,364.21831,650View SEC Filing Icon  
5/25/2017Sell5,600$29.57$165,592.00823,861View SEC Filing Icon  
5/23/2017Sell14,400$29.57$425,808.00822,961View SEC Filing Icon  
5/8/2017Sell15,000$23.11$346,650.00833,261View SEC Filing Icon  
1/24/2017Sell100,000$15.79$1,579,000.00926,158View SEC Filing Icon  
8/16/2016Sell40,000$17.92$716,800.00967,258View SEC Filing Icon  
7/15/2016Sell5,000$15.45$77,250.00932,258View SEC Filing Icon  
6/29/2016Sell5,000$15.01$75,050.00932,258View SEC Filing Icon  
See Full Table

Jason N. Gorevic Buying and Selling Activity at Teladoc Health

This chart shows Jason N Gorevic's buying and selling at Teladoc Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Teladoc Health Company Overview

Teladoc Health logo
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Read More

Today's Range

Now: $151.41
Low: $147.26
High: $152.85

50 Day Range

MA: $154.88
Low: $144.46
High: $171.36

2 Week Range

Now: $151.41
Low: $129.74
High: $308.00

Volume

2,106,268 shs

Average Volume

3,268,784 shs

Market Capitalization

$23.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.25
Next Plant-Based Unicorn
The plant-based industry has been ignited. Pay close attention to this stock.
Learn more.